Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Value of Serum Inhibin B/FSH Ratio in Estimating Pathology Results in Patients Undergoing Micro-TESE Due to Azoospermia

NCT07415928 is registered in ClinicalTrials.gov with Elazıg Fethi Sekin Sehir Hastanesi as lead sponsor.

NCT NCT07415928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07415928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Value of Serum Inhibin B/FSH Ratio in Estimating Pathology Results in Patients Undergoing Micro-TESE Due to Azoospermia
Lead sponsor
Elazıg Fethi Sekin Sehir Hastanesi
Phase
Observational
Overall status
Completed
Start date
January 10, 2026
Completion date
February 5, 2026
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

azoospermia, nonobstructive, non-obstructive azoospermia